<DOC>
	<DOCNO>NCT02885155</DOCNO>
	<brief_summary>The purpose study determine prognostic value echocardiographic parameter comparison clinical hemodynamic parameter pulmonary arterial hypertension ( PAH ) . A secondary purpose study analyze disease evolution 3 6 month . In pulmonary fibrosis demonstrate variation clinical paraclinical parameter 2 examination prognostic interest . In study prognostic value variation echocardiographic parameter initial examination echocardiography 3 6 month evaluate . Another secondary purpose create common database Pneumology , Cardiology Epidemiology department prospective registration new case PAH follow patient treatment .</brief_summary>
	<brief_title>Contribution Echocardiography Prognostic Evaluation Pulmonary Arterial Hypertension</brief_title>
	<detailed_description>Pulmonary arterial hypertension ( PAH ) rare pathology poor prognosis median survival lower 3 year absence specific treatment . The prognostic evaluation base clinical hemodynamic data need right cardiac catheterization . It show prognosis depend essentially severity right ventricular dysfunction . Recently , various echocardiographic parameter derive new technique tissue Doppler validate evaluation right ventricular function . Some use prognostic factor cardiac insufficiency , PAH . This observational retrospective prospective study . Usual PAH assessment include complete clinical paraclinical evaluation . History physical examination ass dyspnea , search sign disease severity quantify functional impact 6 min-walking test . An echocardiography right cardiac catheterization realize patient . Clinical consultation patient control echocardiographic hemodynamic examination program regular interval . The demonstration prognostic value echocardiographic parameter could diminish right cardiac catheterization .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<criteria>Mean pulmonary artery pressure &gt; 25 mmHg hemodynamics accord Venice classification : Idiopathic PAH associate know risk factor ( anorectic , portal hypertension , connective tissue disease , particular scleroderma also lupus , congenital heart disease Eisenmenger syndrome , HIV infection ) Atrial fibrillation Poor echogenicity PAH associate another factor , thromboembolic disease , respiratory insufficiency , leave heart disease mitral aortic valvulopathy</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>